CellReady: Our roots in Cell Therapy

Cell Easy’s story is rooted in the heart of cell therapy research, and this invaluable experience shapes every action we take to help you bring life-saving treatments forward.

Vials of ASCs (Adipose-Derived Stem Cells) cell ready. - Cell Easy

Our Origins

Our journey began with early clinical Mesenchymal Stem Cell (MSC) programs at the French Blood Establishment (EFS). Cell-Easy licensed an innovative large-scale culture process for Adipose-Derived Stem Cells (ASCs) on adherent surfaces.

ASCs are remarkable cells, recognized for their natural ability to regenerate tissue, modulate immune responses, and support repair processes. While early autologous trials demonstrated their potential, treating one patient at a time was neither sustainable nor scalable. To efficiently reach more patients, we transformed the autologous process into an allogeneic one and created CellReady, our proprietary GMP-grade allogeneic ASC platform. This platform enables us to expand cells from a single healthy donor under controlled conditions, producing thousands of clinical doses for patients.

Benefits of CellReady:

  • Expand cells from a single healthy donor
  • Produce multiple clinical doses for multiple patients
  • Fully xeno-free, reproducible, scalable, and GMP-compliant manufacturing process

Every step has been continuously refined to ensure clinical translatability and reliable performance.

Flowchart and cell culture data for the Cell Ready process. The top diagram illustrates the transition from a sample (blood bag) to SVF Bank (Small Vials), followed by expansion to Cell Bank (Medium Vials), and finally the large-scale output of the Cell Ready product (Large Vials).

Clinical Programs using CellReady

In collaboration with CHU Toulouse, our Adipose derived MSCs are applied across five clinical programs:

Program NameIndicationClinical Phase
A3DAlzheimer’s diseasePhase 1 (First-in-Human)
AlloFistCrohn’s disease with perianal fistulasPhase 1/2
ADUSE
Systemic sclerosis — ischemic digital ulcers & possibly oral ulcersPhase 2
AMUSEOral ulcers associated with systemic sclerosisPhase 1
AlloDreamPeripheral limb ischemiaPhase 1

Discover more about Cell Easy